The entities intend for their latest pair-up to progress new approaches to multimodal precision oncology.
Opus Genetics (IRD) rated Hold: valuation hinges on AAV gene therapy success. Track LCA5 Phase 3, 2026 data catalysts & ...
Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...
A major mouse study found that some inherited traits are passed down through epigenetic changes that break the classic rules ...
An international team led by University of Manchester scientists has created the most detailed picture yet of how genetic differences shape the way the human eye works. The breakthrough could help ...
As predictive medicine advances, legal scholars warn that decades-old federal guidelines could set up a potential clash between your genes and your job.
A new study suggests that the long-standing Mendelian view of genetics has some blind spots.
Yeast’s emergence as a model organism reshaped scientific discovery in cell biology, genetics, and more.